Plaintiffs Seek To Expand Valsartan MDL To Include 2 Similar Drugs
WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) on Sept. 26 heard arguments on a plaintiffs’ motion to expand the scope of the valsartan NDMA multidistrict litigation to include...To view the full article, register now.
Already a subscriber? Click here to view full article